CoChat
Sign Up
Cited by 217Hormonal and reproductive studiesMenopause: Health Impacts and TreatmentsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men

Ärnlöv, Johan, Pencina, Michael J., Amin, Shreyasee, Nam, Byung-Ho, Benjamin, Emelia J., Murabito, Joanne M., Wang, Thomas J., Knapp, Philip E., D'Agostino, Ralph B., Bhasin, Shalendar, Vasan, Ramachandran S.·2006·Annals of Internal Medicine
DOI 10.7326/0003-4819-145-3-200608010-00005
Open this paper in CoChat — free account

Abstract

BACKGROUND: Data suggest that endogenous sex hormones (testosterone, dehydroepiandrosterone sulfate [DHEA-S], and estradiol) influence cardiovascular disease (CVD) risk factors and vascular function. Yet, prospective studies relating sex hormones to CVD incidence in men have yielded inconsistent results. OBJECTIVE: To examine the association of circulating sex hormone levels and CVD risk in men. DESIGN: Prospective cohort study. SETTING: Community-based study in Framingham, Massachusetts. PARTICIPANTS: 2084 middle-aged white men without CVD at baseline. MEASUREMENTS: The authors used multivariable Cox regression to relate baseline levels of testosterone, DHEA-S, and estradiol to the incidence of CVD (coronary, cerebrovascular, or peripheral vascular disease or heart failure) during 10 years of follow-up. RESULTS: During follow-up, 386 men (18.5%) experienced a first CVD event. After adjustment for baseline standard CVD risk factors, higher estradiol level was associated with lower risk for CVD (hazard ratio per SD increment in log estradiol, 0.90 [95% CI, 0.82 to 0.99]; P = 0.035). The authors observed effect modification by age: Higher estradiol levels were associated with lower CVD risk in older (median age >56 years) men (hazard ratio per SD increment, 0.86 [CI, 0.78 to 0.96]; P = 0.005) but not in younger (median age < or =56 years) men (hazard ratio per SD increment, 1.11 [CI, 0.89 to 1.38]; P = 0.36). The association of higher estradiol level with lower CVD incidence remained robust in time-dependent Cox models (updating standard CVD risk factors during follow-up). Serum testosterone and DHEA-S levels were not statistically significantly associated with incident CVD. LIMITATIONS: Sex hormone levels were measured only at baseline, and the findings may not be generalizable to women and nonwhite people. CONCLUSIONS: In the community-based sample, a higher serum estradiol level was associated with lower risk for CVD events in older men. The findings are consistent with the hypothesis that endogenous estrogen has vasculoprotective influences in men.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-145-3-200608010-00005

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 59 references

Research works printed but not linked: 6

  1. 10.1210/jcem.87.8.8762 · DOI
  2. Tilvis RS, 1999, Aging (Milano), 11, 30
  3. Kajinami K, 2004, Coron Artery Dis, 15, 199
  4. Jilma B, 1996, J Clin Endocrinol Metab, 81, 2350
  5. Ohshige A, 1996, Artery, 22, 115
  6. 1967, Surg Gynecol Obstet, 124, 1011

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Ärnlöv, J., Pencina, M. J., Amin, S., Nam, B.-H., Benjamin, E. J., Murabito, J. M., Wang, T. J., Knapp, P. E., D'Agostino, R. B., Bhasin, S., & Vasan, R. S.
Affiliations
  • Boston University (US)
  • From the National Heart, Lung, and Blood Institute's Framingham Heart Study, National Institutes of Health, Bethesda, Maryland; Boston University School of Medicine, Boston University, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts; Mayo Clinic College of Medicine, Rochester, Minnesota; and Uppsala University, Uppsala, Sweden.
ORCID
Venue
Annals of Internal Medicine
Publisher
American College of Physicians
Published
2006-08-01
Volume
145
Issue
3
Pages
176-184
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
DOI
10.7326/0003-4819-145-3-200608010-00005
OpenAlex
W1550493347
Cited by
217
References
59
Citations by year
2025: 5 · 2024: 5 · 2023: 3 · 2022: 12 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 16 · 2012: 19
FWCI
12.00
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k23hl074077-03, n01hc25195-41-0-1)
  • National Heart, Lung, and Blood Institute (2K24 HL 04334, N01‐HC25195, K23-HL-074077, K24HL004334)
  • National Institute of Neurological Disorders and Stroke (6R01NS17950, R01NS017950)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
endogenous sex hormones, cardiovascular disease incidence, estradiol, testosterone, dehydroepiandrosterone sulfate, men, coronary artery disease, cerebrovascular disease, peripheral vascular disease, heart failure, age effect modification, vascular protection, Framingham Heart Study
MeSH terms
Cardiovascular Diseases, Estradiol, Follow-Up Studies, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk Factors, Testosterone, Incidence, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review